Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97


Optimized surface markers for the prospective isolation of high-quality hiPSCs using flow cytometry selection.

Abujarour R, Valamehr B, Robinson M, Rezner B, Vranceanu F, Flynn P.

Sci Rep. 2013;3:1179. doi: 10.1038/srep01179. Epub 2013 Jan 31.


Scalable expansion of human induced pluripotent stem cells in the defined xeno-free E8 medium under adherent and suspension culture conditions.

Wang Y, Chou BK, Dowey S, He C, Gerecht S, Cheng L.

Stem Cell Res. 2013 Nov;11(3):1103-16. doi: 10.1016/j.scr.2013.07.011. Epub 2013 Aug 9.


Induced pluripotent stem cells from GMP-grade hematopoietic progenitor cells and mononuclear myeloid cells.

Ohmine S, Dietz AB, Deeds MC, Hartjes KA, Miller DR, Thatava T, Sakuma T, Kudva YC, Ikeda Y.

Stem Cell Res Ther. 2011 Nov 16;2(6):46. doi: 10.1186/scrt87.


Non-integrating episomal plasmid-based reprogramming of human amniotic fluid stem cells into induced pluripotent stem cells in chemically defined conditions.

Slamecka J, Salimova L, McClellan S, van Kelle M, Kehl D, Laurini J, Cinelli P, Owen L, Hoerstrup SP, Weber B.

Cell Cycle. 2016;15(2):234-49. doi: 10.1080/15384101.2015.1121332.


Identification of unsafe human induced pluripotent stem cell lines using a robust surrogate assay for pluripotency.

Polanco JC, Ho MS, Wang B, Zhou Q, Wolvetang E, Mason E, Wells CA, Kolle G, Grimmond SM, Bertoncello I, O'Brien C, Laslett AL.

Stem Cells. 2013 Aug;31(8):1498-510. doi: 10.1002/stem.1425.


Surface marker epithelial cell adhesion molecule and E-cadherin facilitate the identification and selection of induced pluripotent stem cells.

Chen HF, Chuang CY, Lee WC, Huang HP, Wu HC, Ho HN, Chen YJ, Kuo HC.

Stem Cell Rev. 2011 Sep;7(3):722-35. doi: 10.1007/s12015-011-9233-y.


Primed pluripotent cell lines derived from various embryonic origins and somatic cells in pig.

Park JK, Kim HS, Uh KJ, Choi KH, Kim HM, Lee T, Yang BC, Kim HJ, Ka HH, Kim H, Lee CK.

PLoS One. 2013;8(1):e52481. doi: 10.1371/journal.pone.0052481. Epub 2013 Jan 11.


Induced pluripotent stem cell lines derived from human gingival fibroblasts and periodontal ligament fibroblasts.

Wada N, Wang B, Lin NH, Laslett AL, Gronthos S, Bartold PM.

J Periodontal Res. 2011 Aug;46(4):438-47. doi: 10.1111/j.1600-0765.2011.01358.x. Epub 2011 Mar 29.


ONSL and OSKM cocktails act synergistically in reprogramming human somatic cells into induced pluripotent stem cells.

Jung L, Tropel P, Moal Y, Teletin M, Jeandidier E, Gayon R, Himmelspach C, Bello F, André C, Tosch A, Mansouri A, Bruant-Rodier C, Bouillé P, Viville S.

Mol Hum Reprod. 2014 Jun;20(6):538-49. doi: 10.1093/molehr/gau012. Epub 2014 Feb 5.


Comparative study of human-induced pluripotent stem cells derived from bone marrow cells, hair keratinocytes, and skin fibroblasts.

Streckfuss-Bömeke K, Wolf F, Azizian A, Stauske M, Tiburcy M, Wagner S, Hübscher D, Dressel R, Chen S, Jende J, Wulf G, Lorenz V, Schön MP, Maier LS, Zimmermann WH, Hasenfuss G, Guan K.

Eur Heart J. 2013 Sep;34(33):2618-29. doi: 10.1093/eurheartj/ehs203. Epub 2012 Jul 12.


piggyBac Transposon Mediated Reprogramming and Flow Cytometry Analysis of CD44 and ICAM1 Cell-Surface Marker Changes.

Brightwell S, Kaji K.

Methods Mol Biol. 2016;1357:285-93. doi: 10.1007/7651_2014_147.


Improved methods for reprogramming human dermal fibroblasts using fluorescence activated cell sorting.

Kahler DJ, Ahmad FS, Ritz A, Hua H, Moroziewicz DN, Sproul AA, Dusenberry CR, Shang L, Paull D, Zimmer M, Weiss KA, Egli D, Noggle SA.

PLoS One. 2013;8(3):e59867. doi: 10.1371/journal.pone.0059867. Epub 2013 Mar 29.


Self-renewal and differentiation capabilities are variable between human embryonic stem cell lines I3, I6 and BG01V.

Tavakoli T, Xu X, Derby E, Serebryakova Y, Reid Y, Rao MS, Mattson MP, Ma W.

BMC Cell Biol. 2009 Jun 5;10:44. doi: 10.1186/1471-2121-10-44.


Early reprogramming regulators identified by prospective isolation and mass cytometry.

Lujan E, Zunder ER, Ng YH, Goronzy IN, Nolan GP, Wernig M.

Nature. 2015 May 21;521(7552):352-6. doi: 10.1038/nature14274. Epub 2015 Apr 1.


Identification of Oct4-activating compounds that enhance reprogramming efficiency.

Li W, Tian E, Chen ZX, Sun G, Ye P, Yang S, Lu D, Xie J, Ho TV, Tsark WM, Wang C, Horne DA, Riggs AD, Yip ML, Shi Y.

Proc Natl Acad Sci U S A. 2012 Dec 18;109(51):20853-8. doi: 10.1073/pnas.1219181110. Epub 2012 Dec 3.


Reversible transformation and de-differentiation of human cells derived from induced pluripotent stem cell teratomas.

Kamada M, Mitsui Y, Matsuo T, Takahashi T.

Hum Cell. 2016 Jan;29(1):1-9. doi: 10.1007/s13577-015-0119-1. Epub 2015 Jun 12.


The timing of retroviral silencing correlates with the quality of induced pluripotent stem cell lines.

Okada M, Yoneda Y.

Biochim Biophys Acta. 2011 Feb;1810(2):226-35. doi: 10.1016/j.bbagen.2010.10.004. Epub 2010 Oct 20.


An imprinted signature helps isolate ESC-equivalent iPSCs.

Lujan E, Wernig M.

Cell Res. 2010 Sep;20(9):974-6. doi: 10.1038/cr.2010.117. Epub 2010 Aug 10. No abstract available.


Human-induced pluripotent stem cells produced under xeno-free conditions.

Ross PJ, Suhr ST, Rodriguez RM, Chang EA, Wang K, Siripattarapravat K, Ko T, Cibelli JB.

Stem Cells Dev. 2010 Aug;19(8):1221-9. doi: 10.1089/scd.2009.0459.


Supplemental Content

Support Center